214 related articles for article (PubMed ID: 15090020)
1. Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod.
Herron MD; Bowen AR; Krueger GG
Int J Dermatol; 2004 Apr; 43(4):300-2. PubMed ID: 15090020
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment.
Coynik D
Cutis; 2000 Dec; 66(6 Suppl):19-24. PubMed ID: 11147087
[TBL] [Abstract][Full Text] [Related]
3. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
[TBL] [Abstract][Full Text] [Related]
4. An observation study evaluating the efficacy of tazarotene plus corticosteroid in treating plaque psoriasis in patients switched from treatment with calcipotriene +/- corticosteroid.
Tanghetti EA;
Cutis; 2000 Dec; 66(6 Suppl):12-8. PubMed ID: 11147086
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.
Quist SR; Gollnick HP
Expert Opin Pharmacother; 2011 Feb; 12(3):451-61. PubMed ID: 21254950
[TBL] [Abstract][Full Text] [Related]
6. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
Tanghetti E; Dhawan S; Green L; Ling M; Downie J; Germain MA; Kasteler JS; Kircik L; Oefelein MG; Draelos Z
J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases.
Ulrich C; Busch JO; Meyer T; Nindl I; Schmook T; Sterry W; Stockfleth E
Br J Dermatol; 2006 Aug; 155(2):451-4. PubMed ID: 16882188
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
Leyden JJ
Cutis; 2004 Oct; 74(4 Suppl):9-15. PubMed ID: 15543714
[TBL] [Abstract][Full Text] [Related]
10. Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
Shalita A
Cutis; 2004 Oct; 74(4 Suppl):4-8. PubMed ID: 15543713
[TBL] [Abstract][Full Text] [Related]
11. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Huang YC; Chou CL; Chiang YY
Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
[TBL] [Abstract][Full Text] [Related]
13. A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study.
Marchetti A; LaPensee K; An P
Clin Ther; 1998; 20(4):851-69. PubMed ID: 9737842
[TBL] [Abstract][Full Text] [Related]
14. Tazarotene 0.1% cream for the treatment of photodamage.
Phillips TJ
Skin Therapy Lett; 2004 Apr; 9(4):1-2. PubMed ID: 15146262
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Sun J; Dou W; Zhao Y; Hu J
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
[TBL] [Abstract][Full Text] [Related]
16. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
17. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
Phillips TJ; Gottlieb AB; Leyden JJ; Lowe NJ; Lew-Kaya DA; Sefton J; Walker PS; Gibson JR;
Arch Dermatol; 2002 Nov; 138(11):1486-93. PubMed ID: 12437455
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and topical therapy.
Lebwohl M
Cutis; 2002 Nov; 70(5 Suppl):5-8. PubMed ID: 12467332
[TBL] [Abstract][Full Text] [Related]
20. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report.
Seckin D; Cerman AA; Yildiz A; Ergun T
J Drugs Dermatol; 2009 May; 8(5):451-4. PubMed ID: 19537367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]